Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Exchange Rate Effect (2021 - 2025)

Arrowhead Pharmaceuticals' Exchange Rate Effect history spans 5 years, with the latest figure at $106000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 255.88% year-over-year to $106000.0; the TTM value through Dec 2025 reached -$227000.0, down 105.58%, while the annual FY2025 figure was -$401000.0, 109.55% down from the prior year.
  • Exchange Rate Effect reached $106000.0 in Q4 2025 per ARWR's latest filing, up from -$24000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $4.3 million in Q3 2024 to a low of -$402000.0 in Q1 2025.
  • Average Exchange Rate Effect over 5 years is $218411.8, with a median of -$24000.0 recorded in 2025.
  • The largest YoY upside for Exchange Rate Effect was 5000.0% in 2023 against a maximum downside of 7500.0% in 2023.
  • A 5-year view of Exchange Rate Effect shows it stood at -$39000.0 in 2021, then plummeted by 212.82% to -$122000.0 in 2022, then surged by 147.54% to $58000.0 in 2023, then tumbled by 217.24% to -$68000.0 in 2024, then soared by 255.88% to $106000.0 in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Exchange Rate Effect are $106000.0 (Q4 2025), -$24000.0 (Q3 2025), and $93000.0 (Q2 2025).